Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey - PubMed (original) (raw)

Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey

Y Yoshizawa et al. J Allergy Clin Immunol. 1999 Feb.

Abstract

Background: Pulmonary fibrosis inevitably develops in patients with chronic hypersensitivity pneumonitis (HP).

Objective: We conducted a nationwide epidemiologic study in Japan to evaluate the frequency and clinical characteristics of chronic HP.

Methods: This report is on 36 cases of chronic HP, including 10 patients with summer-type HP, 5 patients with home-related HP, 7 patients with bird fancier's lung, 5 patients with isocyanate-induced HP, 4 patients with farmer's lung, and 5 patients with other types of chronic HP. Chronic HP was further subgrouped into 2 types: one type of patients were first seen with chronic disease (9 patients), and the other type became chronic with fibrosis after repeated acute episodes (27 patients).

Results: The upper lung field was frequently involved in chronic HP (17%). Ground-glass opacities were observed in 57% and air space consolidation in 30% of the patients. Honeycombing was apparent in 37%. Twenty-six of 28 patients had antibodies to the presumptive antigens. Five of 8 patients with chronic HP were positive for antigen-induced lymphocyte proliferation. In 2 cases patients did not have detectable antibodies to causative antigens, although antigen-induced lymphocyte proliferation was detectable. The ratio of CD4 to CD8 in BAL lymphocytes was lowest in isocyanate-induced HP (mean 0.22) and tended to be high in farmer's lung and bird fancier's lung. Granulomas were observed in 39% and Masson bodies in 42% of specimens on histologic examination. Administration of prednisolone was effective in 58% of patients.

Conclusions: The insidious form of chronic HP has probably been misdiagnosed as idiopathic pulmonary fibrosis when a good history was not taken and immunologic (especially antigen-induced lymphocyte proliferation) and BAL testing were not counted.

PubMed Disclaimer

Cited by

Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H, Iwamoto H, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N. Tanahashi H, et al. Respir Res. 2024 May 4;25(1):195. doi: 10.1186/s12931-024-02825-y. Respir Res. 2024. PMID: 38704585 Free PMC article.
Clinical characteristics and outcomes of hypersensitivity pneumonitis in South Korea.
Zo S, Chung MP, Yoo HY, Lee KS, Han J, Chung MJ, Yoo H. Zo S, et al. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231212304. doi: 10.1177/17534666231212304. Ther Adv Respir Dis. 2023. PMID: 37970818 Free PMC article. Review.
Machine learning-based metabolism-related genes signature, single-cell RNA sequencing, and experimental validation in hypersensitivity pneumonitis.
He J, Wang B, Chen M, Song L, Li H. He J, et al. Medicine (Baltimore). 2023 Oct 6;102(40):e34940. doi: 10.1097/MD.0000000000034940. Medicine (Baltimore). 2023. PMID: 37800807 Free PMC article.
Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?
Pereira JO, Fernandes V, Alfaro TM, Freitas S, Cordeiro CR. Pereira JO, et al. Life (Basel). 2023 Feb 17;13(2):565. doi: 10.3390/life13020565. Life (Basel). 2023. PMID: 36836922 Free PMC article. Review.
Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis.
Ejima M, Okamoto T, Suzuki T, Anzai T, Takahashi K, Miyazaki Y. Ejima M, et al. BMC Pulm Med. 2021 Jul 19;21(1):243. doi: 10.1186/s12890-021-01608-1. BMC Pulm Med. 2021. PMID: 34281549 Free PMC article.

Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey - PubMed (original) (raw)